Shares of Davis-based Arcadia Biosciences Inc. rose 13 percent on news that its safflower nutritional supplement for cats has been granted approval from the Food and Drug Administration.
Arcadia’s (Nasdaq: RKDA) shares rose 91 cents to $7.90 on Friday, when the company announced the approval.
The Arcadia safflower product needed FDA approval because it is a genetically modified organism. The company worked on safflower genetics to boost safflower oil’s content of gamma-linolenic acid, or GLA,…
